Yale-led Team Pursuing Gene Expression Signature to Predict Poor Outcomes in Pulmonary Fibrosis | GenomeWeb

A group of researchers from several US institutions has identified a gene expression signature that can predict which patients with idiopathic pulmonary fibrosis are likely to have a worse outcome, based on how long they lived with the disease before death or before requiring a lung transplant.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.